Corvus Pharmaceuticals (CRVS) is Initiated by Guggenheim to Buy

Corvus Pharmaceuticals (CRVS) was Initiated by Guggenheim to “Buy”. Guggenheim advised their investors in a research report released on Apr 18, 2016.

Many Wall Street Analysts have commented on Corvus Pharmaceuticals. Corvus Pharmaceuticals was Initiated by Credit Suisse to “Outperform” on Apr 18, 2016.

Corvus Pharmaceuticals

Leave a Reply

Corvus Pharmaceuticals - Is it time to Sell?

Top Brokerage Firms are advising their investors on Corvus Pharmaceuticals. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.